13F HOLDINGS REPORT
Lynx1 Capital Management LP
Quarter ended Q2 2024 · Filed August 14, 2024 · Accession 0001892688-24-000091
Total Value
$275.9M
Positions
17
Other Managers
1
Confidential Omitted
No
Holdings (17)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MERUS N V | N5749R100 | 1,206,707 | $71.4M | 25.88% |
| 2 | STOKE THERAPEUTICS INC | STOK | 5,185,191 | $70.1M | 25.39% |
| 3 | GH RESEARCH PLC | GHRS | 3,966,726 | $46.3M | 16.76% |
| 4 | C4 THERAPEUTICS INC | CCCC | 6,880,527 | $31.8M | 11.52% |
| 5 | TSCAN THERAPEUTICS INC | TCRX | 5,224,600 | $30.6M | 11.08% |
| 6 | CULLINAN THERAPEUTICS INC | CGEM | 377,323 | $6.6M | 2.38% |
| 7 | ALLOGENE THERAPEUTICS INC | ALLO | 2,228,295 | $5.2M | 1.88% |
| 8 | LONGBOARD PHARMACEUTICALS IN | 54300N103 | 167,317 | $4.5M | 1.64% |
| 9 | PASSAGE BIO INC | PASG | 5,057,629 | $4.0M | 1.46% |
| 10 | CABALETTA BIO INC | CABA | 492,103 | $3.7M | 1.33% |
| 11 | IBIO INC | IBIO | 240,763 | $508,010 | 0.18% |
| 12 | BIONOMICS LIMITED | 09063M205 | 599,673 | $459,949 | 0.17% |
| 13 | PIERIS PHARMACEUTICALS INC | 720795202 | 43,499 | $426,756 | 0.15% |
| 14 | KINIKSA PHARMACEUTICALS INTL | G52694109 | 9,500 | $177,365 | 0.06% |
| 15 | CENTESSA PHARMACEUTICALS PLC | CNTA | 17,400 | $157,122 | 0.06% |
| 16 | KORRO BIO INC | KRRO | 3,800 | $128,706 | 0.05% |
| 17 | VYNE THERAPEUTICS INC | VYNE | 16,194 | $31,902 | 0.01% |